Typically, the lowest rate of correct responses in the control group concerned the management of anemia in patients with chronic kidney failure experiencing some trouble with iron supplements, erythropoietin, and situations with hemoglobin levels greater than 11 g/dL and high ferritin. This evidence concerns the gene EPO and chronic renal failure syndrome.